We must highlight how numerous authors have described the prognostic importance of p16 in pharyngeal carcinoma; p16 is currently considered the strongest independent prognostic factor in these tumors and is associated with better survival in patients with high expression than in patients with low expression of p16 [35]. Here, CDKN2A is linked to carcinoma of pharynx.